MENU
MENUVolume : VIII, Issue : VIII, August - 2019
A PROSPECTIVE OBSERVATIONAL STUDY ON ROLE OF GEFITINIB, AS FIRST LINE MONOTHERAPY IN EGFR GENE MUTATION POSITIVE NSCLC PATIENTS.
Dr Naveen Ravel, Dr Mukesh Bang
Abstract :
Keywords :
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Overall response rate (ORR) Progression Free Survival (PFS).
Article:
Download PDF
DOI : https://www.doi.org/10.36106/gjra
Cite This Article:
A PROSPECTIVE OBSERVATIONAL STUDY ON ROLE OF GEFITINIB, AS FIRST LINE MONOTHERAPY IN EGFR GENE MUTATION POSITIVE NSCLC PATIENTS., Dr Naveen Ravel, Dr Mukesh Bang GLOBAL JOURNAL FOR RESEARCH ANALYSIS : Volume-8 | Issue-8 | August-2019
Number of Downloads : 143
References :
A PROSPECTIVE OBSERVATIONAL STUDY ON ROLE OF GEFITINIB, AS FIRST LINE MONOTHERAPY IN EGFR GENE MUTATION POSITIVE NSCLC PATIENTS., Dr Naveen Ravel, Dr Mukesh Bang GLOBAL JOURNAL FOR RESEARCH ANALYSIS : Volume-8 | Issue-8 | August-2019
